Academics and Industry Partners Launch Novel Study for Easing COVID-19 Restrictions
The SAfER study—supported by Genome BC, Genome Canada, and industry partners—will track and collect data over time on infection, immunity, contacts, and clinical symptoms for 1,500 volunteer employees at BC based biotechnology companies.
Format
JPEG
Source
Genome British Columbia